DECADRON

LOE Approaching

dexamethasone sodium phosphate

NDAINJECTIONINJECTABLE
Approved
Oct 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4

Mechanism of Action

CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids, (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs, including dexamethasone, are primarily used for their potent…

Clinical Trials (4)

NCT02770807Phase 3Completed

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients

Started Mar 2017
176 enrolled
Nervous System DiseaseGenetic Syndrome
NCT01255358Phase 2Completed

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients

Started Feb 2011
22 enrolled
Nervous System DisorderGenetic Syndrome
NCT01159574Phase 2Completed

Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma

Started Aug 2010
121 enrolled
Multiple Myeloma
NCT00091624Phase 1Completed

A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)

Started Mar 2003
77 enrolled
Multiple Myeloma